The significance of pelvis positron emission tomography and magnetic resonance tomography for surgical planning in patients with high risk prostate cancer
https://doi.org/10.18027/2224-5057-2019-9-1-38-41
Abstract
The article concerns the diagnostic value of PET/CT scan for surgical planning in patients with high‑risk prostate cancer.
About the Authors
M. Sh. Shikhzadaev
Federal State Budgetary Institution Russian Research Center for Radiology and Surgical Technologies named after Academician A. M. Granov of the Ministry of Health of Russia
Russian Federation
Russian Federation
Makhmud Sh. Shikhzadaev, urologic oncologist, postgraduate student of the Department of Urologic Oncology
Saint Petersburg
M. I. Shkolnik
Federal State Budgetary Institution Russian Research Center for Radiology and Surgical Technologies named after Academician A. M. Granov of the Ministry of Health of Russia
Russian Federation
Russian Federation
Mikhail I. Shkolnik, MD, PhD, DSc, urologic oncologist, Head of the Department of Urologic Oncology
Saint Petersburg
A. A. Stanjevskiy
Federal State Budgetary Institution Russian Research Center for Radiology and Surgical Technologies named after Academician A. M. Granov of the Ministry of Health of Russia
Russian Federation
Russian Federation
Andrey A. Stanjevskiy, MD, PhD, DSc, radiologist, leading specialist in radiology and radiation therapy, Deputy Head for Scientific Issues
Saint Petersburg
O. A. Bogomolov
Federal State Budgetary Institution Russian Research Center for Radiology and Surgical Technologies named after Academician A. M. Granov of the Ministry of Health of Russia
Russian Federation
Russian Federation
Oleg A. Bogomolov, urologic oncologist of the Department of Urologic Oncology and Gynecologic Oncology Surgery
Saint Petersburg
A. L. Dolbov
Federal State Budgetary Institution Russian Research Center for Radiology and Surgical Technologies named after Academician A. M. Granov of the Ministry of Health of Russia
Russian Federation
Russian Federation
Artem L. Dolbov, radiologist of the Department of Positron Emission Tomography
Saint Petersburg
References
1. Шихзадаев М. Ш, Школьник М. И, Жаринов Г. М, Богомолов О. А, Прохоров Д. Г. Современные подходы в лечении местно распространенного рака предстательной железы // Вопросы онкологии, 2018. Том 64, № 4.
2. Al Monajjed R. Prostate cancer screening: controversies and suggested solutions/R. Al Monajjed, C. Arsov, P. Albers // Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. — 2018. — doi: 10.1007/s00103-018-2840-x.
3. Sensitivity, Specificity, and Predictors of Positive 68 Ga Prostate specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta analysis/M. Perera, N. Papa, D. Christidis [et al.] // Eur Urol. — 2016. — Vol. 70, No. 6. — P. 926–937. — doi: 10.1016/j.eururo.2016.06.021.
4. Diagnostic Efficacy of (68) Gallium PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer/T. Maurer, J. E. Gschwend, I. Rauscher [et al.] // J Urol. — 2016. — Vol. 195, No. 5. — P. 1436–1443. — doi: 10.1016/j.juro.2015.12.025.
5. Jadvar H. Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer/H. Jadvar // Abdom Radiol (NY). — 2016. — Vol. 41, No. 5. — P. 889–898. — doi: 10.1007/s00261-015-0563-0.
6. 68 Ga PSMA Positron Emission Tomography/Computed Tomography Provides Accurate Staging of Lymph Node Regions Prior to Lymph Node Dissection in Patients with Prostate Cancer/A. Herlemann, V. Wenter, A. Kretschmer [et al.] // Eur Urol. — 2016. — Vol. 70, No. 4. — P. 553–557. — doi: 10.1016/j.eururo.2015.12.051.
7. Clinical impact of 68 Ga prostate specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer with rising prostate specific antigen after treatment with curative intent: preliminary analysis of a multidisciplinary approach/S. Albisinni, C. Artigas, F. Aoun [et al.] // BJU Int. — 2017. — Vol. 120, No. 2. — P. 197–203. — doi: 10.1111/bju.13739.
8. The Role of Positron Emission Tomography With (68) Gallium (Ga) — Labeled Prostate specific Membrane Antigen (PSMA) in the Management of Patients With Organ confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy/B. P. Rai, R. P. Baum, A. Patel [et al.] // Urology. — 2016. — Vol. 95. — P. 11–15. — doi: 10.1016/urology.2015.12.048.
9. Prospective evaluation of 68 Gallium prostate specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer/P. J. van Leeuwen, L. Emmett, B. Ho [et al.] // BJU Int. — 2017. — Vol. 119, No. 2. — P. 209–215. — doi: 10.1111/bju.13 540.
10. Nonspecific Uptake of 68 Ga Prostate Specific Membrane Antigen in Diseases other than Prostate Malignancy on Positron Emission Tomography/Computed Tomography Imaging: A Pictorial Assay and Review of Literature/D. Malik, A. Sood, B. R. Mittal [et al.] // Indian J Nucl Med. — 2018. — Vol. 33, No. 4. — P. 317–325. — doi: 10.4103/ijnm.IJNM_81_18.
11. Assessment of 68 Ga PSMA 11 PET positivity predictive factors in prostate cancer/A. L. Gutiérrez Cardo, A. Pérez Duarte, S. F. García Argüello [et al.] // Rev Esp Med Nucl Imagen Mol. — 2018. — doi: 10.1016/j.remn.2018.09.006.
12. Prostate imaging features that indicate benign or malignant pathology on biopsy/C. E. Lovegrove, M. Matanhelia, J. Randeva [et al.] // Transl Androl Urol. — 2018. — No. 7, Suppl. 4. — P. S420 S435. — doi: 10.21037/tau.2018.07.06.
13. Ланг Т. А. Как описывать статистику в медицине/Т. А. Ланг, М. Сесик; пер. с англ. под ред. В. П. Леонова. — М.: Практическая медицина, 2011. — 480 с.
14. Jansson K. F. et al. Concordance of tumor differentiation among brothers with prostate cancer // European urology. –2012. — T.62. №. 4. — C. 656–661.
15. Ferlay J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 // International journal of cancer. — 2015. — T. 136. — №. 5.
Review
For citations:
Shikhzadaev M.Sh., Shkolnik M.I., Stanjevskiy A.A., Bogomolov O.A., Dolbov A.L. The significance of pelvis positron emission tomography and magnetic resonance tomography for surgical planning in patients with high risk prostate cancer. Malignant tumours. 2019;9(1):38-41. (In Russ.) https://doi.org/10.18027/2224-5057-2019-9-1-38-41
Views:
2253
Email this article 